Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Visual plus nonvisual hallucinations in Parkinson's disease: Development and evolution over 10 years

Identifieur interne : 001278 ( Main/Exploration ); précédent : 001277; suivant : 001279

Visual plus nonvisual hallucinations in Parkinson's disease: Development and evolution over 10 years

Auteurs : Christopher G. Goetz [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Bichun Ouyang [États-Unis]

Source :

RBID : ISTEX:D2E11E9C25F2DCE4B265B69BDF12B32C48C9D7D8

Descripteurs français

English descriptors

Abstract

The objective of the study was to assess the development and evolution of visual and nonvisual hallucinations in patients with Parkinson's disease over 10 years. Hallucinations increase over time, but minimal attention has been placed on nonvisual domains. We studied 60 patients with Parkinson's disease who had never hallucinated at baseline and followed them over 10 years. The Rush Hallucination Inventory monitored frequency and type (visual, auditory, tactile, olfactory) of hallucinations at baseline and after 0.5, 1.5, 4, 6, and 10 years. Descriptive statistics were applied, and general estimating equation modeling assessed longitudinal risks. Over 10 years, visual hallucinations were endorsed by patients more frequently than other sensory modalities. Whereas isolated visual hallucinations dominated the early hallucination profile, visual plus nonvisual hallucinations accounted for progressively higher proportions of hallucinators over 10 years: 0.5 years, 0%; 4 years, 26%; 6 years, 47%; 10 years, 60% (odds ratio, 1.17; confidence interval, 1.01–1.37; P = .04). Once visual plus nonvisual hallucinations developed, the risk of continuing to have multidomain hallucinations was high (odds ratio, 3.67; confidence interval, 1.13–11.93; P = .03). Hallucination severity was highly associated with current visual plus nonvisual hallucinations (odds ratio, 4.06; confidence interval, 2.93–5.61; P < .0001) and the continuation of multidomain hallucinations (odds ratio, 1.58; confidence interval, 1.12–2.24; P = .01). Whereas visual hallucinations in isolation are classic in Parkinson's disease, nonvisual hallucinations emerge over time, and the combination of visual with nonvisual hallucinations predominates in late Parkinson's disease. To capture the breadth and severity of hallucinations in chronically hallucinating patients with Parkinson's disease, screening inventories and practice‐based interviews must include questions on both visual and nonvisual components. © 2011 Movement Disorder Society

Url:
DOI: 10.1002/mds.23835


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Visual plus nonvisual hallucinations in Parkinson's disease: Development and evolution over 10 years</title>
<author>
<name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name>
</author>
<author>
<name sortKey="Stebbins, Glenn T" sort="Stebbins, Glenn T" uniqKey="Stebbins G" first="Glenn T." last="Stebbins">Glenn T. Stebbins</name>
</author>
<author>
<name sortKey="Ouyang, Bichun" sort="Ouyang, Bichun" uniqKey="Ouyang B" first="Bichun" last="Ouyang">Bichun Ouyang</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D2E11E9C25F2DCE4B265B69BDF12B32C48C9D7D8</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1002/mds.23835</idno>
<idno type="url">https://api.istex.fr/document/D2E11E9C25F2DCE4B265B69BDF12B32C48C9D7D8/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001512</idno>
<idno type="wicri:Area/Istex/Curation">001512</idno>
<idno type="wicri:Area/Istex/Checkpoint">000010</idno>
<idno type="wicri:doubleKey">0885-3185:2011:Goetz C:visual:plus:nonvisual</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:21755536</idno>
<idno type="wicri:Area/PubMed/Corpus">001083</idno>
<idno type="wicri:Area/PubMed/Curation">001083</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000F96</idno>
<idno type="wicri:Area/Ncbi/Merge">003347</idno>
<idno type="wicri:Area/Ncbi/Curation">003347</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003347</idno>
<idno type="wicri:Area/Main/Merge">001331</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:11-0481740</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000378</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002940</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000323</idno>
<idno type="wicri:doubleKey">0885-3185:2011:Goetz C:visual:plus:nonvisual</idno>
<idno type="wicri:Area/Main/Merge">001913</idno>
<idno type="wicri:Area/Main/Curation">001278</idno>
<idno type="wicri:Area/Main/Exploration">001278</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Visual plus nonvisual hallucinations in Parkinson's disease: Development and evolution over 10 years</title>
<author>
<name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois</wicri:regionArea>
<placeName>
<region type="state">Illinois</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Stebbins, Glenn T" sort="Stebbins, Glenn T" uniqKey="Stebbins G" first="Glenn T." last="Stebbins">Glenn T. Stebbins</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois</wicri:regionArea>
<placeName>
<region type="state">Illinois</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ouyang, Bichun" sort="Ouyang, Bichun" uniqKey="Ouyang B" first="Bichun" last="Ouyang">Bichun Ouyang</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois</wicri:regionArea>
<placeName>
<region type="state">Illinois</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2011-10">2011-10</date>
<biblScope unit="vol">26</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="2196">2196</biblScope>
<biblScope unit="page" to="2200">2200</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">D2E11E9C25F2DCE4B265B69BDF12B32C48C9D7D8</idno>
<idno type="DOI">10.1002/mds.23835</idno>
<idno type="ArticleID">MDS23835</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged</term>
<term>Disease Progression</term>
<term>Evolution</term>
<term>Female</term>
<term>Hallucinations (classification)</term>
<term>Hallucinations (etiology)</term>
<term>Humans</term>
<term>Longitudinal Studies</term>
<term>Male</term>
<term>Mental Status Schedule</term>
<term>Middle Aged</term>
<term>Nervous system diseases</term>
<term>Parkinson Disease (complications)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Time Factors</term>
<term>Treatment</term>
<term>Visual hallucination</term>
<term>dopaminergic therapy</term>
<term>hallucinations</term>
<term>longitudinal data</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="en">
<term>Hallucinations</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Hallucinations</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Disease Progression</term>
<term>Female</term>
<term>Humans</term>
<term>Longitudinal Studies</term>
<term>Male</term>
<term>Mental Status Schedule</term>
<term>Middle Aged</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Evolution</term>
<term>Hallucination visuelle</term>
<term>Maladie de Parkinson</term>
<term>Pathologie du système nerveux</term>
<term>Traitement</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The objective of the study was to assess the development and evolution of visual and nonvisual hallucinations in patients with Parkinson's disease over 10 years. Hallucinations increase over time, but minimal attention has been placed on nonvisual domains. We studied 60 patients with Parkinson's disease who had never hallucinated at baseline and followed them over 10 years. The Rush Hallucination Inventory monitored frequency and type (visual, auditory, tactile, olfactory) of hallucinations at baseline and after 0.5, 1.5, 4, 6, and 10 years. Descriptive statistics were applied, and general estimating equation modeling assessed longitudinal risks. Over 10 years, visual hallucinations were endorsed by patients more frequently than other sensory modalities. Whereas isolated visual hallucinations dominated the early hallucination profile, visual plus nonvisual hallucinations accounted for progressively higher proportions of hallucinators over 10 years: 0.5 years, 0%; 4 years, 26%; 6 years, 47%; 10 years, 60% (odds ratio, 1.17; confidence interval, 1.01–1.37; P = .04). Once visual plus nonvisual hallucinations developed, the risk of continuing to have multidomain hallucinations was high (odds ratio, 3.67; confidence interval, 1.13–11.93; P = .03). Hallucination severity was highly associated with current visual plus nonvisual hallucinations (odds ratio, 4.06; confidence interval, 2.93–5.61; P < .0001) and the continuation of multidomain hallucinations (odds ratio, 1.58; confidence interval, 1.12–2.24; P = .01). Whereas visual hallucinations in isolation are classic in Parkinson's disease, nonvisual hallucinations emerge over time, and the combination of visual with nonvisual hallucinations predominates in late Parkinson's disease. To capture the breadth and severity of hallucinations in chronically hallucinating patients with Parkinson's disease, screening inventories and practice‐based interviews must include questions on both visual and nonvisual components. © 2011 Movement Disorder Society</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Illinois</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Illinois">
<name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name>
</region>
<name sortKey="Ouyang, Bichun" sort="Ouyang, Bichun" uniqKey="Ouyang B" first="Bichun" last="Ouyang">Bichun Ouyang</name>
<name sortKey="Stebbins, Glenn T" sort="Stebbins, Glenn T" uniqKey="Stebbins G" first="Glenn T." last="Stebbins">Glenn T. Stebbins</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001278 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001278 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:D2E11E9C25F2DCE4B265B69BDF12B32C48C9D7D8
   |texte=   Visual plus nonvisual hallucinations in Parkinson's disease: Development and evolution over 10 years
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024